<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; disclosure</title>
	<atom:link href="http://symptomadvice.com/tag/disclosure/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Hemispherx Biopharma shares rise on FDA extension of new drug application</title>
		<link>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/</link>
		<comments>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 07:34:13 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[fatigue symptoms]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[investment advice]]></category>
		<category><![CDATA[investment strategy]]></category>
		<category><![CDATA[regard]]></category>
		<category><![CDATA[suitability]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/</guid>
		<description><![CDATA[No investment advice The Company &#105;&#115; a publisher and &#105;&#115; not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised by the Financial Services Authority (FSA). &#121;&#111;&#117; understand and agree that &#110;&#111; content published on the Site constitutes a recommendation that &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy &#105;&#115; suitable &#111;&#114; advisable for &#097;&#110;&#121; specific person. &#121;&#111;&#117; [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="" style="float:left;clear:both;margin:0 15px 15px 0" />No investment advice
<p>The Company &#105;&#115; a publisher and &#105;&#115; not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised by the Financial Services Authority (FSA). &#121;&#111;&#117; understand and agree that &#110;&#111; content published on the Site constitutes a recommendation that &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy &#105;&#115; suitable &#111;&#114; advisable for &#097;&#110;&#121; specific person. &#121;&#111;&#117; &#102;&#117;&#114;&#116;&#104;&#101;&#114; understand that &#110;&#111;&#110;&#101; &#111;&#102; the information providers &#111;&#114; their affiliates &#119;&#105;&#108;&#108; advise &#121;&#111;&#117; personally &#099;&#111;&#110;&#099;&#101;&#114;&#110;&#105;&#110;&#103; the nature, potential, advisability, value &#111;&#114; suitability &#111;&#102; &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, investment strategy, &#111;&#114; other matter.</p>
<p>You understand that the Site &#109;&#097;&#121; &#099;&#111;&#110;&#116;&#097;&#105;&#110; opinions &#102;&#114;&#111;&#109; time &#116;&#111; time &#119;&#105;&#116;&#104; regard &#116;&#111; securities mentioned in other products, including company related products, and that those opinions &#109;&#097;&#121; be different &#102;&#114;&#111;&#109; those obtained by using another product related &#116;&#111; the Company. &#121;&#111;&#117; understand and agree that contributors &#109;&#097;&#121; write &#097;&#098;&#111;&#117;&#116; securities in &#119;&#104;&#105;&#099;&#104; &#116;&#104;&#101;&#121; &#111;&#114; their firms have a position, and that &#116;&#104;&#101;&#121; &#109;&#097;&#121; trade such securities for their &#111;&#119;&#110; account. In cases where the position &#105;&#115; held at the time &#111;&#102; publication and such position &#105;&#115; &#107;&#110;&#111;&#119;&#110; &#116;&#111; the Company, appropriate disclosure &#105;&#115; made. &#104;&#111;&#119;&#101;&#118;&#101;&#114;, &#121;&#111;&#117; understand and agree that at the time &#111;&#102; &#097;&#110;&#121; transaction that &#121;&#111;&#117; make, &#111;&#110;&#101; &#111;&#114; more contributors &#109;&#097;&#121; have a position in the securities written &#097;&#098;&#111;&#117;&#116;. &#121;&#111;&#117; understand that price and other data &#105;&#115; supplied by sources believed &#116;&#111; be reliable, that the calculations &#104;&#101;&#114;&#101;&#105;&#110; are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers &#111;&#114; &#097;&#110;&#121; other person &#111;&#114; entity, and &#109;&#097;&#121; not be complete &#111;&#114; accurate.</p>
<p>From time &#116;&#111; time, reference &#109;&#097;&#121; be made in &#111;&#117;&#114; marketing materials &#116;&#111; prior articles and opinions we have published. These references &#109;&#097;&#121; be selective, &#109;&#097;&#121; reference &#111;&#110;&#108;&#121; a portion &#111;&#102; an article &#111;&#114; recommendation, and are likely not &#116;&#111; be current. As markets change continuously, previously published information and data &#109;&#097;&#121; not be current and &#115;&#104;&#111;&#117;&#108;&#100; not be relied upon.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Picture of Health: Beware who you sleep with: herpes symptoms not always visible &#8211; Health care, wellness, food nutrition, exercise, medical research news by reporters Kelly Brewington, Meredith Cohn and Andrea K. Walker &#8211; baltimoresun.com</title>
		<link>http://symptomadvice.com/picture-of-health-beware-who-you-sleep-with-herpes-symptoms-not-always-visible-health-care-wellness-food-nutrition-exercise-medical-research-news-by-reporters-kelly-brewington-meredith-cohn-a/</link>
		<comments>http://symptomadvice.com/picture-of-health-beware-who-you-sleep-with-herpes-symptoms-not-always-visible-health-care-wellness-food-nutrition-exercise-medical-research-news-by-reporters-kelly-brewington-meredith-cohn-a/#comments</comments>
		<pubDate>Wed, 11 May 2011 22:17:07 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[herpes symptoms]]></category>
		<category><![CDATA[appearance]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[herpes]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[virus]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/picture-of-health-beware-who-you-sleep-with-herpes-symptoms-not-always-visible-health-care-wellness-food-nutrition-exercise-medical-research-news-by-reporters-kelly-brewington-meredith-cohn-a/</guid>
		<description><![CDATA[Don&#8217;t judge a person by&#160;&#104;&#105;&#115; &#111;&#114; her&#160;appearance. Especially, &#105;&#102; you&#8217;re intimate with &#116;&#104;&#101;&#109;. A new study &#111;&#110; herpes &#102;&#111;&#117;&#110;&#100; that your sexual partner may &#098;&#101; free &#111;&#102; symptoms such as genital lesions, &#098;&#117;&#116; that doesn&#8217;t &#109;&#101;&#097;&#110; he &#111;&#114; &#115;&#104;&#101; &#105;&#115; not carrying &#116;&#104;&#101; sexually transmitted disease. And yes, they can pass &#105;&#116; &#111;&#110; &#116;&#111; you [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2011/05/1305152228-90.jpg" style="clear:both;clear:both;margin:0 15px 15px 0" />
<p>Don&#8217;t judge a person by&nbsp;&#104;&#105;&#115; &#111;&#114; her&nbsp;appearance.</p>
<p>Especially, &#105;&#102; you&#8217;re intimate with &#116;&#104;&#101;&#109;. </p>
<p>A new study &#111;&#110; herpes &#102;&#111;&#117;&#110;&#100; that your sexual partner may &#098;&#101; free &#111;&#102; symptoms such as genital lesions, &#098;&#117;&#116; that doesn&#8217;t &#109;&#101;&#097;&#110; he &#111;&#114; &#115;&#104;&#101; &#105;&#115; not carrying &#116;&#104;&#101; sexually transmitted disease. </p>
<p>And yes, they can pass &#105;&#116; &#111;&#110; &#116;&#111; you even &#105;&#102; &#105;&#116; doesn&#8217;t &quot;look&quot; like they have &#105;&#116;, &#097;&#099;&#099;&#111;&#114;&#100;&#105;&#110;&#103; &#116;&#111; &#116;&#104;&#101; study &#116;&#111; &#098;&#101; published in tomorrow&#8217;s Journal &#111;&#102; &#116;&#104;&#101; American Medical Association. &#097;&#098;&#111;&#117;&#116; 16 percent &#111;&#102; adults in &#116;&#104;&#101; United States have &#116;&#104;&#101; herpes simplex type 2 virus, &#098;&#117;&#116; &#111;&#110;&#108;&#121; 10 &#116;&#111; 25 percent with herpes &#115;&#104;&#111;&#119; symptoms, &#116;&#104;&#101; study &#115;&#097;&#105;&#100;.</p>
<p>Scientists &#102;&#111;&#117;&#110;&#100; that viral shedding &#111;&#110; &#116;&#104;&#101; genital skin that can&#8217;t necessarily &#098;&#101; seen &#099;&#111;&#117;&#108;&#100; cause &#116;&#104;&#101; disease &#116;&#111; &#098;&#101; passed &#111;&#110;.</p>
<p>Many people &#097;&#114;&#101; engaging in sexual activity not knowing they &#097;&#114;&#101; &nbsp;&#097;&#116; risk &#111;&#102; passing &#116;&#104;&#101; virus &#111;&#110; &#116;&#111; their partners.</p>
<p>Herpes &#105;&#115; &#111;&#110;&#101; &#111;&#102; &#116;&#104;&#101; most common sexually transmitted diseases in &#116;&#104;&#101; world with an estimated 536 million people&nbsp;infected with &#105;&#116;.</p>
<p>The researchers &#115;&#097;&#105;&#100; condom use, drug therapy &#097;&#110;&#100; disclosure &#111;&#102; &#116;&#104;&#101; disease &#116;&#111; partners can help curb &#116;&#104;&#101; spread &#111;&#102; herpes.</p>
<p>But &#116;&#104;&#101;&#115;&#101; methods have &#104;&#097;&#100; limited impact &#098;&#101;&#099;&#097;&#117;&#115;&#101; so &#109;&#097;&#110;&#121; people don&#8217;t know they have herpes.</p>
<p>So get tested &#097;&#110;&#100; make sure your partner&nbsp;does too.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/picture-of-health-beware-who-you-sleep-with-herpes-symptoms-not-always-visible-health-care-wellness-food-nutrition-exercise-medical-research-news-by-reporters-kelly-brewington-meredith-cohn-a/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proactive Investors NA &#8211; Corcept Therapeutics achieves 87% response rate in phase 3 study for Cushing&#8217;s Syndrome drug</title>
		<link>http://symptomadvice.com/proactive-investors-na-corcept-therapeutics-achieves-87-response-rate-in-phase-3-study-for-cushings-syndrome-drug/</link>
		<comments>http://symptomadvice.com/proactive-investors-na-corcept-therapeutics-achieves-87-response-rate-in-phase-3-study-for-cushings-syndrome-drug/#comments</comments>
		<pubDate>Tue, 11 Jan 2011 16:00:10 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[hormone symptoms]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[regard]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/proactive-investors-na-corcept-therapeutics-achieves-87-response-rate-in-phase-3-study-for-cushings-syndrome-drug/</guid>
		<description><![CDATA[No investment advice The Company is a publisher &#097;&#110;&#100; is not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised &#098;&#121; the Financial Services Authority (FSA). &#121;&#111;&#117; understand &#097;&#110;&#100; agree that no content published on the Site constitutes a recommendation that any particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy is suitable &#111;&#114; advisable &#102;&#111;&#114; any specific person. &#121;&#111;&#117; [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2011/01/1294761610-64.jpg" style="clear:both;clear:both;margin:0 15px 15px 0" />No investment advice
<p>The Company is a publisher &#097;&#110;&#100; is not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised &#098;&#121; the Financial Services Authority (FSA). &#121;&#111;&#117; understand &#097;&#110;&#100; agree that no content published on the Site constitutes a recommendation that any particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy is suitable &#111;&#114; advisable &#102;&#111;&#114; any specific person. &#121;&#111;&#117; further understand that none &#111;&#102; the information providers &#111;&#114; their affiliates &#119;&#105;&#108;&#108; advise &#121;&#111;&#117; personally concerning the nature, potential, advisability, &#118;&#097;&#108;&#117;&#101; &#111;&#114; suitability &#111;&#102; any particular security, portfolio &#111;&#102; securities, transaction, investment strategy, &#111;&#114; &#111;&#116;&#104;&#101;&#114; matter.</p>
<p>You understand that the Site may contain opinions from time &#116;&#111; time &#119;&#105;&#116;&#104; regard &#116;&#111; securities mentioned in &#111;&#116;&#104;&#101;&#114; products, including company related products, &#097;&#110;&#100; that &#116;&#104;&#111;&#115;&#101; opinions may be &#100;&#105;&#102;&#102;&#101;&#114;&#101;&#110;&#116; from &#116;&#104;&#111;&#115;&#101; obtained &#098;&#121; using &#097;&#110;&#111;&#116;&#104;&#101;&#114; product related &#116;&#111; the Company. &#121;&#111;&#117; understand &#097;&#110;&#100; agree that contributors may write about securities in &#119;&#104;&#105;&#099;&#104; they &#111;&#114; their firms have a position, &#097;&#110;&#100; that they may trade such securities &#102;&#111;&#114; their own account. In cases where the position is held at the time &#111;&#102; publication &#097;&#110;&#100; such position is &#107;&#110;&#111;&#119;&#110; &#116;&#111; the Company, appropriate disclosure is made. &#104;&#111;&#119;&#101;&#118;&#101;&#114;, &#121;&#111;&#117; understand &#097;&#110;&#100; agree that at the time &#111;&#102; any transaction that &#121;&#111;&#117; make, &#111;&#110;&#101; &#111;&#114; more contributors may have a position in the securities written about. &#121;&#111;&#117; understand that price &#097;&#110;&#100; &#111;&#116;&#104;&#101;&#114; data is supplied &#098;&#121; sources believed &#116;&#111; be reliable, that the calculations herein are made using such data, &#097;&#110;&#100; that &#110;&#101;&#105;&#116;&#104;&#101;&#114; such data &#110;&#111;&#114; such calculations are guaranteed &#098;&#121; these sources, the Company, the information providers &#111;&#114; any &#111;&#116;&#104;&#101;&#114; person &#111;&#114; entity, &#097;&#110;&#100; may not be complete &#111;&#114; &#097;&#099;&#099;&#117;&#114;&#097;&#116;&#101;.</p>
<p>From time &#116;&#111; time, reference may be made in our marketing materials &#116;&#111; prior articles &#097;&#110;&#100; opinions &#119;&#101; have published. These references may be selective, may reference only a &#112;&#111;&#114;&#116;&#105;&#111;&#110; &#111;&#102; &#097;&#110; article &#111;&#114; recommendation, &#097;&#110;&#100; are &#108;&#105;&#107;&#101;&#108;&#121; not &#116;&#111; be current. &#097;&#115; markets change continuously, previously published information &#097;&#110;&#100; data may not be current &#097;&#110;&#100; &#115;&#104;&#111;&#117;&#108;&#100; not be relied upon.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/proactive-investors-na-corcept-therapeutics-achieves-87-response-rate-in-phase-3-study-for-cushings-syndrome-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
